3rd Quarter - Report

ELEKTA, INC. for ELEKTA, INC.

Firm
Client
Income
—
Expenses
$50,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to oncology treatment products and services; Issues pertaining to value-based payment models for radiation therapy

LobbyistCovered position, as disclosed
ROBERT D THOMAS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Issues related to oncology treatment products and services; Issues pertaining to the security and cybersecurity of critical infrastructure and connected devices

LobbyistCovered position, as disclosed
ROBERT D THOMAS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Veterans VET

Supporting access to medical therapies

LobbyistCovered position, as disclosed
ROBERT D THOMAS —

Contacted: SENATE

Budget/Appropriations BUD

Issues pertaining to the study of radioisotopes in the delivery of health care services

LobbyistCovered position, as disclosed
ROBERT D THOMAS —

Contacted: HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.